The study, which was published in the Annals of Surgical Oncology, compared the outcomes of two groups of patients. One group received the melphalan hepatic delivery system treatment, while the other received the standard care.

Clinical trial shows new treatment for a rare and aggressive cancer improves survival rates

The phase 3 clinical trial, published recently in JAMA Oncology and sponsored by Polaris Pharmaceuticals, has unveiled a breakthrough in the treatment of malignant pleural mesothelioma (MPM), a rare and often rapidly fatal form of cancer associated with asbestos exposure and which has limited therapeutic options. The trial found that a combination treatment of traditional […]

About Hashtag: HealthNews